Filana Therapeutics, Inc. (FLNA) — Financial Flexibility Index
Filana Therapeutics, Inc. (FLNA) has a Financial Flexibility Index of -0.10x as of June 2026. Free cash flow of $-3.83 Million (operating CF $-3.85 Million minus capex $21.00K) represents 0% of total liabilities ($40.29 Million). Check FLNA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Filana Therapeutics, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Filana Therapeutics, Inc. across 4 annual periods. For the full cash flow conversion analysis, see FLNA cash generation efficiency.
Annual Financial Flexibility Index for Filana Therapeutics, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Filana Therapeutics, Inc.. Explore Filana Therapeutics, Inc. debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.72x | $-31.67 Million | $-32.25 Million | $43.95 Million | ▲ +92.7% |
| 2024 | -9.88x | $-116.83 Million | $-116.93 Million | $11.83 Million | ▼ -71.8% |
| 2023 | -5.75x | $-81.61 Million | $-82.03 Million | $14.20 Million | ▲ +43.9% |
| 2022 | -10.25x | $-74.80 Million | $-77.51 Million | $7.29 Million | — |